MONTVALE, N.J., May 4 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its first quarter 2006 financial results on Thursday, May 11, 2006, before the U.S. financial markets open. Management will provide a Company update and discuss the first quarter results during a conference call on Thursday, May 11, 2006, at 9:00 a.m. EDT. Jim Sulat, President and Chief Executive Officer, and Dr. David Lowe, Chief Scientific Officer will host the conference call.
Investors and other interested parties may access the call as follows: Date: Thursday, May 11, 2006 Time: 9:00 a.m. EDT Telephone (U.S.): 866.203.3436 Telephone (international): 617.213.8849 Participant Passcode: 59889999 Webcast: http://www.memorypharma.com under the "Investors" section
An audio replay of the conference call will be available from 11:00 a.m. EDT on Thursday, May 11, 2006, until Thursday, May 18, 2006. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 12047110. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.CONTACT: Jzaneen Lalani, Vice President, Legal Affairs of MemoryPharmaceuticals Corp., +1-201-802-7249; or Laura Perry of Stern InvestorRelations, Inc., +1-212-362-1200
Web site: http://www.memorypharmaceuticals.com/
